Amplia Therapeutics Limited
2 clinical trials · Sponsor
◉ Watch Amplia Therapeutics Limited
| Record | Firm | Date |
|---|---|---|
| A Study of Narmafotinib Given in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic Cancer (NCT07026279) | Amplia Therapeutics Limited | 2025-08-18 |
| ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer (NCT05355298) | Amplia Therapeutics Limited | 2022-05-31 |
Track Amplia Therapeutics Limited automatically
Every clearance here is in the API, with alerts when new ones post.